DOCSLIB.ORG

Výročná Správa LF 2017

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Výročná Správa LF 2017 SLOVENSKÁ ZDRAVOTNÍCKA UNIVERZITA V BRATISLAVE VÝROČNÁ SPRÁVA O ČINNOSTI LEKÁRSKEJ FAKULTY SLOVENSKEJ ZDRAVOTNÍCKEJ UNIVERZITY V BRATISLAVE ZA ROK 2017 1 VÝROČNÁ SPRÁVA O ČINNOSTI LEKÁRSKEJ FAKULTY SLOVENSKEJ ZDRAVOTNÍCKEJ UNIVERZITY V BRATISLAVE ZA ROK 2017 Bratislava, marec 2018 2 Obsah: I. Základné informácie o Lekárskej fakulte: ............................................................................. 4 II. Prehľad najdôležitejších faktov a činností LF SZU .............................................................. 6 III. Informácie o poskytovanom vysokoškolskom vzdelaní ...................................................... 6 IV. Informácie o poskytovaní ďalšieho vzdelávania .................................................................. 9 V. Informácie o výskumnej, umeleckej a ďalšej tvorivej činnosti LF SZU ......................... 13 VI. Habilitačné konania a konania na vymenúvania profesorov ........................................... 19 VII. Akademická mobilita zamestnancov .................................................................................... 19 VIII. Podpora študentov ................................................................................................................. 20 IX. Rozvoj LF SZU ......................................................................................................................... 21 X. Systém kvality ......................................................................................................................... 22 XI. Kontaktné údaje ..................................................................................................................... 22 XII. Prílohy .................................................................................................................................... 233 3 I. Základné informácie o Lekárskej fakulte: Názov vysokej školy: Slovenská zdravotnícka univerzita. Názov fakulty: Lekárska fakulta Poslanie fakulty: Zabezpečiť pregraduálne vzdelávanie v odbore všeobecné lekárstvo v slovenskom a anglickom jazyku a v odbore zubné lekárstvo Zabezpečiť postgraduálne vzdelávanie lekárov, farmaceutov a iných zdravotníckych pracovníkov s vysokoškolským vzdelaním v súlade s odporúčaním UEMS a príslušných smerníc EU a príslušnými vykonávacími predpismi vlády SR a MZ SR Podieľať sa na kontinuálnom medicínskom vzdelávaní. Sídlo fakulty: Limbová 12, 833 03 Bratislava Výučbové základne a ostatné súčasti LF majú pôsobisko v Bratislave aj mimo Bratislavy Dekan fakulty: prof. MUDr. Anna REMKOVÁ, DrSc. Prodekani fakulty: RNDr. Juraj GAŠPAROVIČ, PhD. prodekan pre štúdium zahraničných študentov doc. MUDr. Katarína FURKOVÁ, CSc., mim. prof. prodekan pre postgraduálne vzdelávanie prof. MUDr. Iveta ŠIMKOVÁ, CSc. prodekan pre zahraničie doc. MUDr. Katarína HOLEČKOVÁ, PhD. prodekan pre pregraduálne štúdium prof. MUDr. Juraj PECHAN, CSc. prodekan pre doktorandské štúdium, habilitačné a vymenúvacie konania RNDr. Zora KRIVOŠÍKOVÁ, PhD. prodekan pre vedu a výskum 4 Predseda Akademického senátu: doc. MUDr. Marian BÁTOVSKÝ, CSc., mim. prof. Podpredseda: doc. MUDr. Igor Rusňák, CSc., mim. prof. Tajomníčka: doc. RNDr. Danica Staneková, CSc. Členovia MUDr. Ivan Brychta, PhD. Mgr. Alena Ofúkaná MUDr. Milan Onderčanin, PhD. MUDr. Tatiana Valkovičová Jozef Imrišek, študent LF Kristína Králiková, študent LF Peter Razzouk, študent LF Mária Spálová, študentka LF Vedecká rada LF : prof. MUDr.REMKOVÁ Anna, DrSc. prof. MUDr.BÁTOVSKÝ Marián, CSc. prof.MUDr.BENETIN Ján, CSc. Dr. h.c.prof.MUDr.BREZA Ján, DrSc. prof.MUDr.BUJDÁK Peter, PhD.. prof.MUDr.ČERNÁK Andrej, DrSc. doc.MUDr.DOLEŽAL Pavel, CSc., mim.prof. doc.MUDr.FURKOVÁ Katarína, CSc.,mim.prof. RNDr. GAŠPAROVIČ Juraj, PhD. doc.MUDr.GAZDÍKOVÁ Katarína, PhD. prof.MUDr.HARUŠTIAK Svetozár, CSc. prof.MUDr.HATALA Róbert, CSc. doc. MUDr. HOLEČKOVÁ Katarína, PhD. prof.MUDr.HOLOMÁŇ Jozef, CSc. prof.MUDr.HRUBIŠKO Mikuláš, CSc. prof. MUDr. HRUŠOVSKÝ Štefan, CSc., Dr.SVS doc.MUDr.KAUŠITZ Juraj, CSc. prof.MUDr.RNDr.KOVÁČ Gustáv, CSc.,MBA prof.MUDr.KRAJČÍK Štefan, CSc. prof.MUDr.KRČMÉRY Vladimír, DrSc. prof. MUDr.KRIŠTÚFEK Peter , CSc. RNDr. KRIVOŠÍKOVÁ Zora , PhD. prof. MUDr. MARKOVSKÁ Neda, CSc. 5 prof.MUDr.OLEJNÍK Juraj, PhD. prof.MUDr.PECHAN Juraj,CSc. doc.MUDr.RUSŇÁK Igor, CSc., mim. prof. doc.PharmDr.SÝKORA Juraj, CSc. prof.MUDr.ŠIMKO Peter, CSc. prof.MUDr.ŠIMKOVÁ Iveta, CSc. prof.MUDr.ŠTEŇO Juraj, DrSc. doc.RNDr. VARGA Ivan, PhD. prof. MUDr. DANKO Ján , CSc. prof. MUDr. DANIHEL Ľudovít, CSc. MUDr.DOLINSKÝ Jozef MUDr. FITZ Otakar MUDr. HAŠKO Tomáš, MPH MUDr.HEGER Tomáš, PhD., MHA MUDr. KALISKÁ Gabriela, CSc. doc.MUDr.KUŽELA Ladislav, CSc. PharmDr. MAZAG Ján Ing. MSOLLY Mongi, MBA prof.MUDr. PELLA Daniel, PhD. prof. MUDr. ŠPÁNIK Stanislav, CSc. Poradné orgány LF: Kolégium dekana fakulty tvoria dekan fakulty, prodekani, predseda akademického senátu a tajomník LF. II. Prehľad najdôležitejších faktov a činností LF SZU Pokračovanie výučby v odbore zubné lekárstvo v ďalších ročníkoch Pokračovanie výučby všeobecného lekárstva v anglickom jazyku v ďalších ročníkoch V roku 2017 Lekárska fakulta pokračuje v Rezidentskom programe, ktorý zahájilo MŠVVŠ SR a v súčasnosti je pod záštitou MZ SR v spolupráci s LF SZU , ktorý je zameraný na podporu špecializačného štúdia zdravotníckych pracovníkov na doplnenie a stabilizáciu stavov kvalifikovaných zdravotníckych pracovníkov v systéme zdravotníctva v špecializačných odboroch všeobecné lekárstvo a pediatria. III. Informácie o poskytovanom vysokoškolskom vzdelaní a) Akreditované študijné programy -Všeobecné lekárstvo -Zubné lekárstvo 6 Lekárska fakulta realizovala výučbu 2 študijných programov: všeobecné lekárstvo a zubné lekárstvo – len v dennej forme prezenčnou metódou štúdia v spojenom prvom a druhom stupni. V treťom stupni štúdia fakulta realizovala 2 študijné programy: vnútorné choroby a chirurgia v dennej a externej forme prezenčnou formou štúdia. V anglickom jazyku realizovala výučbu 1 študijného programu - všeobecné lekárstvo- General Medicine -len v dennej forme prezenčnou metódou štúdia v spojenom prvom a druhom stupni. Tabuľka č. 15: Zoznam akreditovaných študijných programov ponúkaných k 1.9.2017 Tabuľka č. 16: Zoznam akreditovaných študijných programov - pozastavenie práva, odňatie práva alebo skončenie platnosti priznaného práva k 31.12. 2017 b) Študenti Na Lekárskej fakulte bolo k 31.10.2017 celkovo 642 študentov, z toho 197 študentov inej štátnej príslušnosti, čo predstavuje 30,69 %. V dennej forme štúdia, v spojenom štúdiu prvého a druhého stupňa bolo zapísaných 590 študentov, z toho 196 študentov inej štátnej príslušnosti, čo predstavuje 33,22 %. V dennej forme štúdia, v treťom stupni štúdia bol zapísaný 1 študent a v externej forme štúdia v treťom stupni štúdia bolo 51 študentov z toho bol 1 študent inej štátnej príslušnosti, čo predstavuje 1,96 %. Tabuľka č. 1: Počet študentov vysokej školy k 31. 10. 2017 Vývoj študentov Počet študentov dennej formy štúdia v jednotlivých rokoch stúpa. V porovnaní s rokom 2016, kedy na Lekárskej fakulte SZU študovalo 542 študentov sa tento počet v roku 2017 zvýšil na 591. V dennej forme štúdia bol nárast počtu študentov o 49 študentov, čo predstavuje nárast 9,04 %. V externej forme štúdia v treťom stupni štúdia počet študentov stúpa. V roku 2016 študovalo na Lekárskej fakulte 44 študentov pričom v roku 2017 to bolo 51 študentov, čo predstavuje nárast o 15,91 %. Tabuľka č. 1a: Vývoj počtu študentov (stav k 31.10. daného roka) c) Akademická mobilita študentov V akademickom roku 2016/2017 LF SZU vyslala 4 študentov na mobilitné pobyty za účelom štúdia. Vrámci programu ERASMUS sa študijného pobytu zúčastnili študenti : 7 Corinna Allgäuer - Albert-Ludwings- University Freiburg, Nemecko Dominik Tobias Weigl - Albert-Ludwings- University Freiburg, Nemecko Adam Ján Figeľ - University of Pavia, Taliansko Michaela Škereňová - University of Pavia, Taliansko Na mobilitné pobyty za účelom stáže vyslala LF SZU v akademickom roku 2016/2017 študentov: Dorota Štupáková - Uniklinikum Salzburg, Rakúsko Panagiota Pardalidou - University of Naples Federico II, Taliansko Radovan Vavrina - University of Verona, Taliansko Zuzana Kasášová - General Hospital Zadar, Chorvátsko Tereza Tekulová - General Hospital Zadar, Chorvátsko Petra Fekiačová - Univerzita Karlova v Prahe, Česká republika František Kiss - Nemocnice milosrdných sester Praha, ČR Martin Demeš - Nemocnice milosrdných sester Praha, ČR Thomas Rozina - Dent clinic Praha, Česká republika Lekárska fakulta SZU v Bratislave prijala na pôde univerzity, za účelom štúdia 4 študentov: Fábio Daniel Marques Garcia- Polytechnic Institute of Lisabon, Portugalsko Luís Filipe do Amaral Feijấ - Polytechnic Institute of Lisabon, Portugalsko Alessandra Ceccaroni - University of Pavia, Taliansko Sarah Macedonio - University of Pavia, Taliansko Tabuľka č. 6: Prehľad akademických mobilít - študenti v akademickom roku 2016/2017 a porovnanie s akademickým rokom 2015/2016 d) Záujem o štúdium a výsledky prijímacieho konania Na Lekársku fakultu sa na spojený prvý a druhý stupeň- denná forma v odboroch všeobecné lekárstvo a zubné lekárstvo celkovo prihlásilo 619 uchádzačov, prijímacích pohovorov sa zúčastnilo celkovo 498 uchádzačov a prijatých bolo celkovo 166 uchádzačov, čo predstavuje 26,82 % prijatých uchádzačov z prihlásených uchádzačov. Zapísaných bolo celkovo 109 uchádzačov, čo predstavuje 65,66 % zapísaných uchádzačov z prijatých uchádzačov. Na študijný program všeobecné lekárstvo bolo prihlásených 486 uchádzačov, prijatých bolo 136 uchádzačov, čo predstavuje 27,98 % prijatých uchádzačov z prihlásených.
Load more

Recommended publications
  • New Species and Changes in Fungal Taxonomy and Nomenclature
    Journal of Fungi Review From the Clinical Mycology Laboratory: New Species and Changes in Fungal Taxonomy and Nomenclature Nathan P. Wiederhold * and Connie F. C. Gibas Fungus Testing Laboratory, Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; [email protected] * Correspondence: [email protected] Received: 29 October 2018; Accepted: 13 December 2018; Published: 16 December 2018 Abstract: Fungal taxonomy is the branch of mycology by which we classify and group fungi based on similarities or differences. Historically, this was done by morphologic characteristics and other phenotypic traits. However, with the advent of the molecular age in mycology, phylogenetic analysis based on DNA sequences has replaced these classic means for grouping related species. This, along with the abandonment of the dual nomenclature system, has led to a marked increase in the number of new species and reclassification of known species. Although these evaluations and changes are necessary to move the field forward, there is concern among medical mycologists that the rapidity by which fungal nomenclature is changing could cause confusion in the clinical literature. Thus, there is a proposal to allow medical mycologists to adopt changes in taxonomy and nomenclature at a slower pace. In this review, changes in the taxonomy and nomenclature of medically relevant fungi will be discussed along with the impact this may have on clinicians and patient care. Specific examples of changes and current controversies will also be given. Keywords: taxonomy; fungal nomenclature; phylogenetics; species complex 1. Introduction Kingdom Fungi is a large and diverse group of organisms for which our knowledge is rapidly expanding.
    [Show full text]
  • New Antifungal Pipeline
    author by John eLibraryR. Perfect Duke University Medical Center Durham, NC [email protected] ESCMID Conflicts: consulting/advisory© committee/research grants. Astellas, Merck, F2G, Cidara, Pfizer, Scynexis, Viamet, Amplyx, Vical, Matinas, Minnetronix author by eLibrary ESCMID © Denning and Bromley. Science 347: 1414- 16, 2015 Why? 1. Attributable Mortality author Candidiasis 40% * by Cryptococcosis 20-30% t Aspergillosis 20%□ 2. Fungicidal Activity ( We treat too long for success!!!) 3. Optimize Combination eLibrary 4. Increasing Spectrum of Antifungal Activity (ex. Lomentospora prolificans) 5. Safety ESCMID * Basettii et al Int. Care Med, 2015 © t Bratton et al PLoS One, 2013 □ Marr et al Ann. Intern Med, 2015 + O N - O OH O O O HO authorH N H N H C 3 N O OHHN + byH3C O HO NH O CH3 N O O H N N HO OH O O OH Biafungin (CD101 Acetate) HO Structural modification yields improvedeLibrary chemical & biological properties • Designed for prolonged PK once weekly dosing in clinical studies potential for improved efficacy vs • Designed for high exposures Candida and Aspergillus infections • Eliminates toxic degradation products potential for improved safety ESCMID intravenous; subcutaneous under • Enables multiple formulations© development ICAAC 2015 Day 14 –STRIVE Study mITT Population Rezafungin Rezafungin Caspofungin 400 mg/400 mg (QWk) 400 mg/200 mg (QWk) 70 mg/50 mg (QD) Response N= 33 N= 31 N= 28 n (%) Overall Response- Success 19 (57.6) 22 (71.0)author 18 (64.3) - Failure 7 (21.2) 6by (19.4) 8 (28.6) - Indeterminate 7 (21.2) 3 (9.7)
    [Show full text]
  • An Assessment of Fungal Occurrence in Treated Drinking Water and Implications to Public Health
    AN ASSESSMENT OF FUNGAL OCCURRENCE IN TREATED DRINKING WATER AND IMPLICATIONS TO PUBLIC HEALTH Report to the Water Research Commission by Memory Tekere, Ntombie Mhlongo, Timothy Sibanda, Ilunga Kamika, and Ramganesh Selvarajan Department of Environmental Science University of South Africa WRC Report No. 2568/1/20 ISBN 978-0-6392-0149-8 May 2020 Obtainable from Water Research Commission Private Bag X03 GEZINA, 0031 [email protected] or download from www.wrc.org.za DISCLAIMER This report has been reviewed by the Water Research Commission (WRC) and approved for publication. Approval does not signify that the contents necessarily reflect the views and policies of the WRC, nor does mention of trade names or commercial products constitute endorsement or recommendation for use. © Water Research Commission Occurrence of fungi in drinking water ¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯ EXECUTIVE SUMMARY ______________________________________________________________________________________ BACKGROUND Safe drinking water is of paramount importance in the protection of public health. Raw water is normally treated to produce drinking water that meets national standards, set according to the acceptable physical, chemical and biological properties. However, it is acknowledged that the final treated drinking water environment is non- sterile, and it hosts a diverse microbiome as total elimination of microorganisms from drinking water during treatment and distribution is impractical. Although the quality of final water leaving the treatment plant can be of acceptable standards, its quality can still deteriorate within the water distribution system. Microbial deterioration of treated drinking water can occur due to a number of reasons which include insufficient disinfectant residual, occurrence of microbial biofilms within the distribution system and contaminant intrusion during breakdown and maintenance of the systems.
    [Show full text]
  • Scedosporium and Lomentospora: an Updated Overview of Underrated
    Scedosporium and Lomentospora: an updated overview of underrated opportunists Andoni Ramirez-Garcia, Aize Pellon, Aitor Rementeria, Idoia Buldain, Eliana Barreto-Bergter, Rodrigo Rollin-Pinheiro, Jardel Vieira Meirelles, Mariana Ingrid D. S. Xisto, Stephane Ranque, Vladimir Havlicek, et al. To cite this version: Andoni Ramirez-Garcia, Aize Pellon, Aitor Rementeria, Idoia Buldain, Eliana Barreto-Bergter, et al.. Scedosporium and Lomentospora: an updated overview of underrated opportunists. Medical Mycol- ogy, Oxford University Press, 2018, 56 (1), pp.S102-S125. 10.1093/mmy/myx113. hal-01789215 HAL Id: hal-01789215 https://hal.archives-ouvertes.fr/hal-01789215 Submitted on 10 Apr 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Medical Mycology, 2018, 56, S102–S125 doi: 10.1093/mmy/myx113 Review Article Review Article Downloaded from https://academic.oup.com/mmy/article-abstract/56/suppl_1/S102/4925971 by SCDU Mediterranee user on 10 April 2019 Scedosporium and Lomentospora: an updated overview of underrated opportunists Andoni Ramirez-Garcia1,∗, Aize Pellon1, Aitor Rementeria1, Idoia Buldain1, Eliana Barreto-Bergter2, Rodrigo Rollin-Pinheiro2, Jardel Vieira de Meirelles2, Mariana Ingrid D. S. Xisto2, Stephane Ranque3, Vladimir Havlicek4, Patrick Vandeputte5,6, Yohann Le Govic5,6, Jean-Philippe Bouchara5,6, Sandrine Giraud6, Sharon Chen7, Johannes Rainer8, Ana Alastruey-Izquierdo9, Maria Teresa Martin-Gomez10, Leyre M.
    [Show full text]
  • Scedosporium and Lomentospora Infections: Contemporary Microbiological Tools for the Diagnosis of Invasive Disease
    Journal of Fungi Review Scedosporium and Lomentospora Infections: Contemporary Microbiological Tools for the Diagnosis of Invasive Disease Sharon C.-A. Chen 1,2,*, Catriona L. Halliday 1,2, Martin Hoenigl 3,4,5 , Oliver A. Cornely 6,7,8 and Wieland Meyer 2,9,10,11 1 Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, New South Wales Health Pathology, Westmead Hospital, Westmead, Sydney, NSW 2145, Australia; [email protected] 2 Marie Bashir Institute for Infectious Diseases & Biosecurity, The University of Sydney, Sydney, NSW 2006, Australia; [email protected] 3 Division of Infectious Diseases and Global Health, University of California San Diego, San Diego, CA 92103, USA; [email protected] 4 Clinical and Translational Fungal-Working Group, University of California San Diego, San Diego, CA 92103, USA 5 Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, 8036 Graz, Austria 6 Department of Internal Medicine, Excellence Centre for Medical Mycology (ECMM), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50923 Cologne, Germany; [email protected] 7 Translational Research Cologne Excellence Cluster on Cellular Responses in Aging-associated Diseases (CECAD), 50923 Cologne, Germany 8 Clinical Trials Centre Cologne (ZKS Koln), 50923 Cologne, Germany 9 Molecular Mycology Research Laboratory, Centre for Infectious Diseases and Microbiology, Clinical School, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Westmead, Sydney, NSW 2006, Australia 10 Westmead Hospital (Research and Education Network), Westmead, NSW 2145, Australia 11 Westmead Institute for Medical Research, Westmead, NSW 2145, Australia * Correspondence: [email protected]; Tel.: +61-2-8890-6255 Abstract: Scedosporium/Lomentospora fungi are increasingly recognized pathogens.
    [Show full text]
  • The Host Immune Response to Scedosporium/Lomentospora
    Journal of Fungi Review The Host Immune Response to Scedosporium/Lomentospora Idoia Buldain, Leire Martin-Souto , Aitziber Antoran, Maialen Areitio , Leire Aparicio-Fernandez , Aitor Rementeria * , Fernando L. Hernando and Andoni Ramirez-Garcia * Fungal and Bacterial Biomics Research Group, Department of Immunology, Microbiology and Parasitology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Barrio Sarriena s/n, 48940 Leioa, Spain; [email protected] (I.B.); [email protected] (L.M.-S.); [email protected] (A.A.); [email protected] (M.A.); [email protected] (L.A.-F.); fl[email protected] (F.L.H.) * Correspondence: [email protected] (A.R.); [email protected] (A.R.-G.) Abstract: Infections caused by the opportunistic pathogens Scedosporium/Lomentospora are on the rise. This causes problems in the clinic due to the difficulty in diagnosing and treating them. This review collates information published on immune response against these fungi, since an understanding of the mechanisms involved is of great interest in developing more effective strategies against them. Sce- dosporium/Lomentospora cell wall components, including peptidorhamnomannans (PRMs), α-glucans and glucosylceramides, are important immune response activators following their recognition by TLR2, TLR4 and Dectin-1 and through receptors that are yet unknown. After recognition, cytokine synthesis and antifungal activity of different phagocytes and epithelial cells is species-specific, high- lighting the poor response by microglial cells against L. prolificans. Moreover, a great number of Scedosporium/Lomentospora antigens have been identified, most notably catalase, PRM and Hsp70 for their potential medical applicability. Against host immune response, these fungi contain evasion mechanisms, inducing host non-protective response, masking fungal molecular patterns, destructing host defense proteins and decreasing oxidative killing.
    [Show full text]
  • Investigation of a Lomentospora Prolificans Case Cluster with Whole
    Medical Mycology Case Reports 29 (2020) 1–4 Contents lists available at ScienceDirect Medical Mycology Case Reports journal homepage: www.elsevier.com/locate/mmcr Investigation of a Lomentospora prolificans case cluster with whole genome sequencing T ∗ Peter Boana,b, , Stanley Pangc, Dianne J. Gardamb, Helen Darraghb, Matthew Wrighta,b, Geoffrey W. Coombsb,c a Fiona Stanley Hospital, 11 Robin Warren Ave, Murdoch, Perth, 6150, Australia b PathWest Laboratory Medicine WA, 11 Robin Warren Ave, Murdoch, Perth, 6150, Australia c Murdoch University, 90 South St, Murdoch, Perth, 6150, Australia ARTICLE INFO ABSTRACT Keywords: Lomentospora prolificans has caused outbreaks in immunocompromised patients. We performed whole genome Lomentospora prolificans sequencing (WGS) on 4 L. prolificans isolates from infections occurring during an 8-month period in the hae- Scedosporium prolificans matology unit at Hospital 1., and 2 isolates from unrelated infections at Hospital 2., showing a high number of Fungal outbreak mutational differences (> 10,000 single nucleotide polymorphisms) between L. prolificans isolates from Hospital Whole genome sequencing 1. Novel typing of isolates by WGS did not demonstrate a single causative strain. Antifungal resistance 1. Introduction complicated by acute graft-versus-host-disease treated with prednisolone and sirolimus, acute kidney injury requiring Lomentospora prolificans is an environmental mold which is found haemodialysis, and intensive care unit admission. He was on particularly in Australia, Spain, Portugal, California and the southern fluconazole prophylaxis. On the 19th May 2015 (Day 0) necrotic soft United States [1]. It characteristically causes clinical infection in im- tissue was noticed at his heel. Swab D0, swab D+2 and tissue D+6 munocompromised hosts and is notable for resistance to antifungals.
    [Show full text]
  • Growth-Inhibitory Effects of Farnesol Against Scedosporium Boydii and Lomentospora Prolificans
    SOUTHEAST ASIAN J TROP MED PUBLIC HEALTH GROWTH-INHIBITORY EFFECTS OF FARNESOL AGAINST SCEDOSPORIUM BOYDII AND LOMENTOSPORA PROLIFICANS Potjaman Pumeesat1,2, Thanwa Wongsuk1,3, Watcharamat Muangkaew1 and Natthanej Luplertlop1,4 1Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok; 2Department of Medical Technology, Faculty of Science and Technology, Bansomdejchaopraya Rajabhat University, Bangkok; 3Department of Clinical Pathology, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok; 4Center for Emerging and Neglected Infectious Diseases, Mahidol University, Salaya Campus, Nakhon Pathom, Thailand Abstract. Scedosporium boydii and Lomentospora prolificans are filamentous fungi reported to cause infection in immunocompromized individuals. We studied the effect of farnesol to inhibit growth of S. boydii and L. prolificans by measur- ing colony diameter and determining minimal effective concentration (MEC).S. boydii and L. prolificans were grown on Sabouraud dextrose agar (SDA) at 37oC for 5 days. Conidia were collected and adjusted to a concentration of 104 conidia/ ml. Twenty microliters of conidia suspension was placed in each well of a six- well plate containing serial dilutions of farnesol (10 µM, 100 µM, 1,000 µM, and 10,000 µM) in SDA. Colony morphology and diameter were observed on days 1, 2, 3, and 4. Farnesol at concentrations of 1,000 µM or higher caused the colony diameter of both S. boydii and L. prolificans to be smaller than untreated controls in a dose-dependent manner. The MEC of farnesol to inhibit growth of both S. boydii and L. prolificans was 3.2 mM. This study reveals the antifungal property of farnesol against S. boydii and L.
    [Show full text]
  • Dual DNA Barcoding for the Molecular Identification of the Agents Of
    Dual DNA Barcoding for the Molecular Identification of the Agents of Invasive Fungal Infections Minh Thuy Vi Hoang, Laszlo Irinyi, Sharon Chen, Tania Sorrell, Wieland Meyer, The Isham Barcoding of Medical Fungi Working Group, Stephane Ranque To cite this version: Minh Thuy Vi Hoang, Laszlo Irinyi, Sharon Chen, Tania Sorrell, Wieland Meyer, et al.. Dual DNA Barcoding for the Molecular Identification of the Agents of Invasive Fungal Infections. Frontiers in Microbiology, Frontiers Media, 2019, 10, 10.3389/fmicb.2019.01647. hal-02481964 HAL Id: hal-02481964 https://hal-amu.archives-ouvertes.fr/hal-02481964 Submitted on 26 Mar 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License fmicb-10-01647 July 17, 2019 Time: 17:32 # 1 ORIGINAL RESEARCH published: 18 July 2019 doi: 10.3389/fmicb.2019.01647 Dual DNA Barcoding for the Molecular Identification of the Agents of Invasive Fungal Infections Minh Thuy Vi Hoang1,2, Laszlo Irinyi1,2,3, Sharon C. A. Chen1,3,4, Tania C. Sorrell1,2,3,
    [Show full text]
  • Novel Small Molecule Antifungals for Invasive Fungal Infections
    University of Kentucky UKnowledge Theses and Dissertations--Pharmacy College of Pharmacy 2020 NOVEL SMALL MOLECULE ANTIFUNGALS FOR INVASIVE FUNGAL INFECTIONS Emily Dennis University of Kentucky, [email protected] Author ORCID Identifier: https://orcid.org/0000-0001-7928-9705 Digital Object Identifier: https://doi.org/10.13023/etd.2020.506 Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Dennis, Emily, "NOVEL SMALL MOLECULE ANTIFUNGALS FOR INVASIVE FUNGAL INFECTIONS" (2020). Theses and Dissertations--Pharmacy. 121. https://uknowledge.uky.edu/pharmacy_etds/121 This Doctoral Dissertation is brought to you for free and open access by the College of Pharmacy at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Pharmacy by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained needed written permission statement(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine) which will be submitted to UKnowledge as Additional File. I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and royalty-free license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known.
    [Show full text]
  • Tássio Brito De Oliveira Fungos Na Compostagem Da
    UNIVERSIDADE ESTADUAL PAULISTA “JÚLIO DE MESQUITA FILHO” unesp INSTITUTO DE BIOCIÊNCIAS – RIO CLARO PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS BIOLÓGICAS (ÁREA: MICROBIOLOGIA APLICADA) TÁSSIO BRITO DE OLIVEIRA FUNGOS NA COMPOSTAGEM DA TORTA DE FILTRO: DIVERSIDADE, GENÔMICA E POTENCIAL BIOTECNOLÓGICO Tese apresentada ao Instituto de Biociências, do Câmpus de Rio Claro, Universidade Estadual Paulista, como parte dos requisitos para obtenção do título de Doutor em Ciências Biológicas (Área: Microbiologia Aplicada). Rio Claro Dezembro – 2016 TÁSSIO BRITO DE OLIVEIRA FUNGOS NA COMPOSTAGEM DA TORTA DE FILTRO: DIVERSIDADE, GENÔMICA E POTENCIAL BIOTECNOLÓGICO Tese apresentada ao Instituto de Biociências, do Câmpus de Rio Claro, Universidade Estadual Paulista, como parte dos requisitos para obtenção do título de Doutor em Ciências Biológicas (Área: Microbiologia Aplicada). Orientador: Prof. Dr. André Rodrigues Co-orientadora: Profª. Drª. Eleni Gomes Rio Claro Dezembro – 2016 589.2 Oliveira, Tássio Brito de O48f Fungos na compostagem da torta de filtro : diversidade, genômica e potencial biotecnológico / Tássio Brito de Oliveira. - Rio Claro, 2016 127 f. : il., figs., gráfs., tabs., fots. Tese (doutorado) - Universidade Estadual Paulista, Instituto de Biociências de Rio Claro Orientador: André Rodrigues Coorientadora: Eleni Gomes 1. Fungos. 2. Pirosequenciamento. 3. Cana-de-açúcar. 4. Enzimas lignocelulolíticas. 5. Tratamento de resíduo. 6. Fungos termofílicos. I. Título. Ficha Catalográfica elaborada pela STATI - Biblioteca da UNESP Campus de Rio Claro/SP AGRADECIMENTOS Ao meu orientador, Dr. André Rodrigues, quem muito admiro pela competência profissional e genialidade, pela oportunidade, dedicação e incentivo à pesquisa durante sua orientação, que me abriu caminhos e diversas colaborações, permitindo meu crescimento profissional e pessoal. À minha co-orientadora, Drª.
    [Show full text]
  • Descriptions of Medical Fungi
    DESCRIPTIONS OF MEDICAL FUNGI THIRD EDITION (revised November 2016) SARAH KIDD1,3, CATRIONA HALLIDAY2, HELEN ALEXIOU1 and DAVID ELLIS1,3 1NaTIONal MycOlOgy REfERENcE cENTRE Sa PaTHOlOgy, aDElaIDE, SOUTH aUSTRalIa 2clINIcal MycOlOgy REfERENcE labORatory cENTRE fOR INfEcTIOUS DISEaSES aND MIcRObIOlOgy labORatory SERvIcES, PaTHOlOgy WEST, IcPMR, WESTMEaD HOSPITal, WESTMEaD, NEW SOUTH WalES 3 DEPaRTMENT Of MOlEcUlaR & cEllUlaR bIOlOgy ScHOOl Of bIOlOgIcal ScIENcES UNIvERSITy Of aDElaIDE, aDElaIDE aUSTRalIa 2016 We thank Pfizera ustralia for an unrestricted educational grant to the australian and New Zealand Mycology Interest group to cover the cost of the printing. Published by the authors contact: Dr. Sarah E. Kidd Head, National Mycology Reference centre Microbiology & Infectious Diseases Sa Pathology frome Rd, adelaide, Sa 5000 Email: [email protected] Phone: (08) 8222 3571 fax: (08) 8222 3543 www.mycology.adelaide.edu.au © copyright 2016 The National Library of Australia Cataloguing-in-Publication entry: creator: Kidd, Sarah, author. Title: Descriptions of medical fungi / Sarah Kidd, catriona Halliday, Helen alexiou, David Ellis. Edition: Third edition. ISbN: 9780646951294 (paperback). Notes: Includes bibliographical references and index. Subjects: fungi--Indexes. Mycology--Indexes. Other creators/contributors: Halliday, catriona l., author. Alexiou, Helen, author. Ellis, David (David H.), author. Dewey Number: 579.5 Printed in adelaide by Newstyle Printing 41 Manchester Street Mile End, South australia 5031 front cover: Cryptococcus neoformans, and montages including Syncephalastrum, Scedosporium, Aspergillus, Rhizopus, Microsporum, Purpureocillium, Paecilomyces and Trichophyton. back cover: the colours of Trichophyton spp. Descriptions of Medical Fungi iii PREFACE The first edition of this book entitled Descriptions of Medical QaP fungi was published in 1992 by David Ellis, Steve Davis, Helen alexiou, Tania Pfeiffer and Zabeta Manatakis.
    [Show full text]